The Angelica Party Clinical Study Of The Treatment Of Liverqi Stagnation Melasma

Objective:Melasma is a common facial hyperpigmentation disorders, its pathogenesis is unclear, and the clinical efficacy of repeatability, Angelica square mentor melasma treatment of liver Qi stagnation repeatability, high efficacyChinese proprietary, but there has been a lack of systematic clinical research.①The observation experience side angelica Treatment clinical efficacy of liver Qi stagnation chloasma;②Explore the application VISIA skin analyzer quantitative and objective evaluation of the clinical efficacy of melasma.Methods:40cases with liver Qi stagnation chloasma were randomly divided into the of Angelica party group and Danzhi spearheading the group,20patients in each morning and at night time, three months of a course of treatment, a monthly recordscore three times recorded. Lesions change by naked eye observation of patients before and after each treatment, clinical symptoms, and ask the patient before and after each treatment statistics TCM syndrome and total score of clinical symptoms, in order to make the changes before and after treatment efficacy evaluation, n addition, each patient before and after treatment are application VISIA digital skin analysis system to detect facial skin as the control system automatically generates absolute score through the quantitative analysis, the image intuitive Statistics skin improvement rate. Finally, compare systematic reviews and clinical efficacy evaluation are the same.Results:1. The two groups after a course of treatment, the patients with TCM symptoms and clinical symptom score values decreased month by month, but the treatment group difference was statistically significant (p<0.05), while the control group was not statistically significant; between the two groups,months of symptom improvement was statistically significant, the first two months there was no statistical significance.2. The treatment group was95.0%, the total efficiency of the control group was65.0%, the two groups (p=0.005<0.01), there are significant differences, with statistical significance.3. After treatment, patients spots and UV spot absolute score decline, compared with before treatment, the difference was statistically significant (p<0.05); treatment group patients the spots and ultraviolet spot absolute score in the decline in the first1,3months after, but the difference was not statistically significant (p>0.05). Monthly spots treatment treatment group compared with the control group, the differences were statistically significant (p<0.05), and UV spots, the difference was not statistically significant (p>0.05).4. Spots and UV spot rate of improvement in the treatment group were38.9%and29.0%,2.3%and0.9%in the control group, two groups, the treatment group improved significantly higher rate, the difference was statistically significant (p<0.05). Conclusion:Angelica Treatment of liver Qi stagnation chloasma reliable, high repeatability; VISIA skin analyzer for quantitative evaluation of the clinical efficacy of melasma.